CompletedNot Applicable

Injectable Platelet Rich Fibrin Versus Platelet Rich Plasma Injection in Degenerative Temporomandibular Joint

Egypt20 participantsStarted 2023-02-22

Plain-language summary

The study aimed to compare the efficacy of injectable platelet rich fibrin (I-PRF) versus platelet rich plasma (PRP) injection in degenerative temporomandibular joint (TMJ).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \>18 years old. * Both sexes. * Patients with unilateral or bilateral temporomandibular joint (TMJ) osteoarthritis according to magnetic resonance imaging (MRI) evaluation. Exclusion Criteria: * Patients under any type of antiplatelet or anticoagulant medications. * Cardiovascular, renal, or hepatic disease. * Diabetes. * Anemia. * Vascular insufficiency. * Peripheral neuropathy. * Previous surgery for TMJ and rheumatoid arthritis.

What they're measuring

Pain improvement

Timeframe: 6 months post-procedure

Trial details

NCT IDNCT07078006

SponsorNasser Institute For Research and Treatment

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2023-12-22

View on ClinicalTrials.gov More Platelet Rich Fibrin trials